Enrollment Complete for STARS Study of Sarizotan for Apnea in Rett Syndrome Patients
Patient enrollment is now complete for the pivotal STARS study investigating the safety, tolerability, and effectiveness of sarizotan in Rett syndrome patients with respiratory abnormalities, Newron Pharmaceuticals announced. Top line results from the Phase 2/3 clinical trial are expected in the last quarter of 2019. Sarizotan was developed…